New drooling treatment shows promise in Year-Long study
NCT ID NCT02610868
First seen Apr 23, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tested a medication called MYOBLOC for adults who have troublesome drooling (sialorrhea) due to conditions like Parkinson's disease, stroke, or ALS. Over one year, 187 participants received repeated injections to see if it safely reduces drooling. The main goal was to check for side effects and track how well the treatment works over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SIALORRHEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Phoenix, Arizona, 85013, United States
-
Study site
Scottsdale, Arizona, 85258, United States
-
Study site
Scottsdale, Arizona, 85259, United States
-
Study site
Loma Linda, California, 92354, United States
-
Study site
Los Angeles, California, 90033, United States
-
Study site
Aurora, Colorado, 80045, United States
-
Study site
Atlantis, Florida, 33462, United States
-
Study site
Boca Raton, Florida, 33486, United States
-
Study site
Orlando, Florida, 32806, United States
-
Study site
Port Charlotte, Florida, 33980, United States
-
Study site
Atlanta, Georgia, 30329, United States
-
Study site
Kansas City, Kansas, 66160, United States
-
Study site
Overland Park, Kansas, 66211, United States
-
Study site
Elkridge, Maryland, 21075, United States
-
Study site
Farmington Hills, Michigan, 48334, United States
-
Study site
St Louis, Missouri, 63110, United States
-
Study site
Las Vegas, Nevada, 89145, United States
-
Study site
Edison, New Jersey, 08818, United States
-
Study site
Centerville, Ohio, 45459, United States
-
Study site
Tulsa, Oklahoma, 74136, United States
-
Study site
Greenville, South Carolina, 29615, United States
-
Study site
Cordova, Tennessee, 38018, United States
-
Study site
San Antonio, Texas, 78229, United States
-
Study site
Kirkland, Washington, 98034, United States
-
Study site
Spokane, Washington, 99202, United States
-
Study site
Tacoma, Washington, 98409, United States
-
Study site
Grodno, 230017, Belarus
-
Study site
Dnipropetrovsk, 49027, Ukraine
-
Study site
Ivano-Frankivsk, 76008, Ukraine
-
Study site
Kharkiv, 61068, Ukraine
-
Study site
Lviv, 79010, Ukraine
-
Study site
Odesa, 65025, Ukraine
-
Study site
Rivne, 33010, Ukraine
-
Study site
Uzhhorod, 88018, Ukraine
-
Study site
Zaporizhzhya, 69600, Ukraine
Conditions
Explore the condition pages connected to this study.